On January 26, Ge Longhui Co., Ltd. (300363.SZ) announced its 2023 annual performance forecast. Net profit profit attributable to shareholders of listed companies during the reporting period was 240 million yuan to 341 million yuan, down 83% — 88% from the same period last year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 285.22 million yuan - 386.22 million yuan, down 80% — 86% from the same period last year; operating income of 3517.4 million yuan to 386,9.14 million yuan, down 45% from the same period last year.
In 2023, the company expects to achieve revenue of 35.17-38.69 billion yuan, a year-on-year decrease of 45%-50%. The main reason is that major orders received by the company in the early stages were delivered more during the same period last year. During the reporting period, the company continued to build an “end-to-end, all-category” pharmaceutical service platform, strengthen market-side capacity building, continuously expand and enrich customer pipelines and product pipelines, and enhance technical capabilities. The company's business revenue showed an increasing trend after eliminating major orders. In 2023, the company expects to achieve net profit attributable to shareholders of listed companies of 240-341 million yuan, a year-on-year decrease of 83%-88%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss is expected to be 2.85-386 million yuan, a year-on-year decrease of 80%-86%.
During the reporting period, the main reasons for the year-on-year decline in the company's net profit attributable to shareholders of listed companies after deducting non-recurring profits and losses: (1) the decline in overall profit due to the decline in the company's operating income during the reporting period; (2) as major orders received by the company completed production in 2022, the gross margin caused by the low utilization rate of the company's overall production capacity during the reporting period; (3) With the company's new business layout, the company's operating expenses and fixed asset depreciation increased more in 2022; (4) With the construction of new business capabilities and the recruitment of teams, the company's labor costs and related expenses from new businesses increased more during the reporting period compared to 2022.